Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) dropped 4.1% during trading on Thursday . The company traded as low as $27.94 and last traded at $28.00. Approximately 334,693 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 505,727 shares. The stock had previously closed at $29.19. […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) CFO Cecilia Jones sold 1,597 shares of the business’s stock in a transaction that occurred on Friday, June 30th. The shares were sold at an average price of $28.36, for a total value of $45,290.92. Following the completion of the sale, the chief financial officer now owns 3,783 […]
StockNews.com initiated coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) in a report published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. A number of other research analysts have also weighed in on the stock. Piper Jaffray Companies began coverage on shares of Agios Pharmaceuticals in a research […]
StockNews.com lowered shares of Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) from a hold rating to a sell rating in a research note published on Tuesday morning. Other equities analysts have also issued research reports about the stock. Piper Sandler assumed coverage on shares of Agios Pharmaceuticals in a research report on Friday, February 3rd. They […]
Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) will issue its quarterly earnings data before the market opens on Thursday, May 4th. Analysts expect the company to announce earnings of ($1.72) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) […]